Literature DB >> 18424667

Borrelia infection and risk of non-Hodgkin lymphoma.

Claudia Schöllkopf1, Mads Melbye, Lars Munksgaard, Karin Ekström Smedby, Klaus Rostgaard, Bengt Glimelius, Ellen T Chang, Göran Roos, Mads Hansen, Hans-Olov Adami, Henrik Hjalgrim.   

Abstract

Reports of the presence of Borrelia burgdorferi DNA in malignant lymphomas have raised the hypothesis that infection with B. burgdorferi may be causally related to non-Hodgkin lymphoma (NHL) development. We conducted a Danish-Swedish case-control study including 3055 NHL patients and 3187 population controls. History of tick bite or Borrelia infection was ascertained through structured telephone interviews and through enzyme-linked immunosorbent assay serum analyses for antibodies against B. burgdorferi in a subset of 1579 patients and 1358 controls. Statistical associations with risk of NHL, including histologic subtypes, were assessed by logistic regression. Overall risk of NHL was not associated with self-reported history of tick bite (odds ratio [OR] = 1.0; 95% confidence interval: 0.9-1.1), Borrelia infection (OR = 1.3 [0.96-1.8]) or the presence of anti-Borrelia antibodies (OR = 1.3 [0.9-2.0]). However, in analyses of NHL subtypes, self-reported history of B. burgdorferi infection (OR = 2.5 [1.2-5.1]) and seropositivity for anti-Borrelia antibodies (OR = 3.6 [1.8-7.4]) were both associated with risk of mantle cell lymphoma. Notably, this specific association was also observed in persons who did not recall Borrelia infection yet tested positive for anti-Borrelia antibodies (OR = 4.2 [2.0-8.9]). Our observations suggest a previously unreported association between B. burgdorferi infection and risk of mantle cell lymphoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18424667      PMCID: PMC2972577          DOI: 10.1182/blood-2007-08-109611

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

Review 1.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

2.  Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa.

Authors:  Alexandra M Levine; Shigetaka Shimodaira; Michael M C Lai
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

3.  Long-term serological follow-up of patients treated for chronic cutaneous borreliosis or culture-positive erythema migrans.

Authors:  H Lomholt; A M Lebech; K Hansen; F Brandrup; L Halkier-Sørensen
Journal:  Acta Derm Venereol       Date:  2000 Sep-Oct       Impact factor: 4.437

4.  Recombinant flagellin A proteins from Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii in serodiagnosis of Lyme borreliosis.

Authors:  J Panelius; P Lahdenne; H Saxen; T Heikkilä; I Seppälä
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

5.  Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States.

Authors:  G S Wood; N V Kamath; J Guitart; P Heald; S Kohler; B R Smoller; L Cerroni
Journal:  J Cutan Pathol       Date:  2001-11       Impact factor: 1.587

Review 6.  Gastric MALT lymphoma: from aetiology to treatment.

Authors:  Ming-Qing Du; Peter G Isaccson
Journal:  Lancet Oncol       Date:  2002-02       Impact factor: 41.316

7.  Antibodies and T-cell reactivity to Borrelia burgdorferi in an asymptomatic population: a study of healthy blood donors in an inland town district in the south-east of Sweden.

Authors:  C Ekerfelt; C Masreliez; M Svenvik; J Ernerudh; M Roberg; P Forsberg
Journal:  Scand J Infect Dis       Date:  2001

8.  Specific cutaneous infiltrates of B-cell chronic lymphocytic leukemia (B-CLL) at sites typical for Borrelia burgdorferi infection.

Authors:  Lorenzo Cerroni; Gerald Höfler; Barbara Bäck; Peter Wolf; Gerlinde Maier; Helmut Kerl
Journal:  J Cutan Pathol       Date:  2002-03       Impact factor: 1.587

9.  Primary cutaneous marginal zone B-cell lymphoma: a molecular and clinicopathologic study of 24 asian cases.

Authors:  Chunmei Li; Hiroshi Inagaki; Tseng-Tong Kuo; Sindy Hu; Mitsukuni Okabe; Tadaaki Eimoto
Journal:  Am J Surg Pathol       Date:  2003-08       Impact factor: 6.394

Review 10.  Lyme borreliosis.

Authors:  Gerold Stanek; Franc Strle
Journal:  Lancet       Date:  2003-11-15       Impact factor: 79.321

View more
  15 in total

1.  Neuroborreliosis and CNS lymphoma: what is the nexus?

Authors:  Carlo Emanuele Saggese; Laura Cecotti; Lucio Giuseppe Lazzarino de Lorenzo
Journal:  Neurol Sci       Date:  2013-08-10       Impact factor: 3.307

2.  The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma.

Authors:  A Carvalho; C Cunha; A J Almeida; N S Osório; M Saraiva; M Teixeira-Coelho; S Pedreiro; E Torrado; N Domingues; A G Gomes-Alves; A Marques; J F Lacerda; M G da Silva; M Gomes; A C Pinto; F Torres; P Rendeiro; P Tavares; M Di Ianni; R Medeiros; P Heutink; P M Bracci; L Conde; P Ludovico; J Pedrosa; P Maciel; L Pitzurra; F Aversa; H Marques; A Paiva; C F Skibola; L Romani; A G Castro; F Rodrigues
Journal:  Genes Immun       Date:  2011-08-25       Impact factor: 2.676

Review 3.  Mantle cell lymphoma: a clinically heterogeneous disease in need of tailored approaches.

Authors:  Bijal D Shah; Peter Martin; Eduardo M Sotomayor
Journal:  Cancer Control       Date:  2012-07       Impact factor: 3.302

Review 4.  Risk factors for etiology and prognosis of mantle cell lymphoma.

Authors:  Yu Wang; Shuangge Ma
Journal:  Expert Rev Hematol       Date:  2014-02-22       Impact factor: 2.929

5.  Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes Project.

Authors:  Karin E Smedby; Joshua N Sampson; Jennifer J Turner; Susan L Slager; Marc Maynadié; Eve Roman; Thomas M Habermann; Christopher R Flowers; Sonja I Berndt; Paige M Bracci; Henrik Hjalgrim; Dennis D Weisenburger; Lindsay M Morton
Journal:  J Natl Cancer Inst Monogr       Date:  2014-08

6.  Epidemiology of Marginal Zone Lymphoma.

Authors:  James R Cerhan; Thomas M Habermann
Journal:  Ann Lymphoma       Date:  2021-03-30

Review 7.  Role of Bacteria in the Incidence of Common GIT Cancers: The Dialectical Role of Integrated Bacterial DNA in Human Carcinogenesis.

Authors:  Sayed K Elagan; Saad J Almalki; M R Alharthi; Mohamed S Mohamed; Mohamed F El-Badawy
Journal:  Infect Drug Resist       Date:  2021-06-01       Impact factor: 4.003

8.  Diagnostic center for primary care patients with nonspecific symptoms and suspected cancer: compliance to workflow and accuracy of tests and examinations.

Authors:  Emelie Stenman; Karolina Palmér; Stefan Rydén; Charlotta Sävblom; Jianguang Ji; Jan Sundquist
Journal:  Scand J Prim Health Care       Date:  2021-05-06       Impact factor: 2.581

9.  A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal.

Authors:  Corry van den Bosch
Journal:  Adv Hematol       Date:  2011-11-29

10.  Evidence of Alternative Modes of B Cell Activation Involving Acquired Fab Regions of N-Glycosylation in Antibody-Secreting Cells Infiltrating the Labial Salivary Glands of Patients With Sjögren's Syndrome.

Authors:  Kristi A Koelsch; Joshua Cavett; Kenneth Smith; Jacen S Moore; Sylvain D Lehoux; Nan Jia; Tim Mather; Syed M S Quadri; Astrid Rasmussen; C Erick Kaufman; David M Lewis; Lida Radfar; Teresa A Scordino; Christopher J Lessard; Biji T Kurien; Richard D Cummings; Judith A James; Kathy L Sivils; A Darise Farris; R Hal Scofield
Journal:  Arthritis Rheumatol       Date:  2018-05-11       Impact factor: 15.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.